GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals & Pharmaceuticals: Credit Rating Reaffirmed

RATING ▲ Positive Development LOW RISK
📅 Filed on BSE: 01 Jul 2026, 04:12 PM IST  ·  BSE ID: 3206f902-6d81-4349-b518-05a085d30ee4
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's creditworthiness for its bank loans has been confirmed by a rating agency.
🤖 AI Summary
  • IOLCP's long-term bank facilities rated CARE A+; Stable, amount Rs. 200 Crore.
  • Short-term bank facilities rated CARE A1+, amount Rs. 500 Crore.
  • CARE Ratings reaffirmed both long-term and short-term credit ratings.
  • Ratings are for banking facilities utilized by the company.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Long Term Bank Facilities
200 CARE A+; Stable
Short Term Bank Facilities
500 CARE A1 +
🏢 How This Affects the Company
💰
Financial Impact
Reaffirmation of credit ratings at stable levels suggests continued lender confidence in the company's financial health and repayment capacity.
⚠️
Risk Impact
Maintained credit ratings indicate no immediate increase in the cost of borrowing or reduced access to funding based on this assessment.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this rating reaffirmation announcement.
👤
Who Is Affected
All shareholders are indirectly affected as stable credit ratings support the company's financial stability and operational continuity.
🔍
Management Signal
The reaffirmation signals management's success in maintaining the company's financial health and its commitment to robust credit management.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Subsequent credit rating reviews by CARE or other agencies.
Company's financial results disclosure for upcoming quarters.
Any changes in the utilization or terms of banking facilities.
LOW RISK This is a routine reaffirmation of credit ratings, indicating stable financial standing.
💡 Investor Takeaway
IOL Chemicals & Pharmaceuticals' credit ratings remain stable with CARE Ratings reaffirming CARE A+ (Stable) for Rs. 200 Crore long-term facilities and CARE A1+ for Rs. 500 Crore short-term facilities.
⚖️ Strengths & Concerns

✅ Positives

  • Long-term bank facilities of Rs. 200 Crore reaffirmed at CARE A+; Stable.
  • Short-term bank facilities of Rs. 500 Crore reaffirmed at CARE A1+.
❓ Frequently Asked Questions
What credit rating has been reaffirmed for IOL Chemicals & Pharmaceuticals' long-term facilities?
CARE Ratings has reaffirmed the rating for IOLCP's long-term bank facilities at CARE A+; Stable.
What is the amount of IOL Chemicals & Pharmaceuticals' long-term banking facilities?
The amount for the long-term bank facilities is Rs. 200 Crore.
What rating did CARE Ratings assign to IOL Chemicals & Pharmaceuticals' short-term facilities?
CARE Ratings reaffirmed the rating for IOLCP's short-term bank facilities at CARE A1+.
What is the total value of IOL Chemicals & Pharmaceuticals' rated banking facilities?
The total value of the reaffirmed banking facilities is Rs. 200 Crore (long-term) and Rs. 500 Crore (short-term).

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.